Refresh

Nagarjuna Drugs Ltd. - Research Center

530064 NAGDRUG Group (XD) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 00

Sales

0.66

Operating profit

-0.11

Interest

0.18

Gross profit

-0.29

EPS (Rs)

-0.74
Half yearly  results in details
Sep ' 00

Other income

-

Stock adjustment

-

Raw material

-

Power and fuel

-

Employee expenses

-

Excise

-

Admin and selling expenses

-

Research and development expenses

-

Expenses capitalised

-

Other expenses

0.77

Provisions made

-

Depreciation

0.10

Taxation

-

Net profit / loss

-0.39

Extra ordinary item

-

Prior year adjustments

-

Equity capital

5.24

Equity dividend rate

-

Agg.of non-prom. shares (Lacs)

-

Agg.of non promotoholding (%)

-

OPM (%)

-16.67

GPM (%)

-

NPM (%)

-
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com